Aspartic Acid

amyloid beta precursor protein ; Homo sapiens







57 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35191674 Aspartic Acid-Assisted Size-Controllable Synthesis of Nanoscale Spherical Covalent Organic Frameworks with Chiral Interfaces for Inhibiting Amyloid-β Fibrillation. 2022 Mar 21 1
2 35347731 Mass spectrometric studies of the variety of beta-amyloid proteoforms in Alzheimer's disease. 2022 Mar 28 1
3 35426495 Enhanced ion mobility resolution of Abeta isomers from human brain using high-resolution demultiplexing software. 2022 Apr 15 2
4 32830360 Membrane dynamics of γ-secretase with the anterior pharynx-defective 1B subunit. 2021 Jan 1
5 33928245 Quantification of N-terminal amyloid-β isoforms reveals isomers are the most abundant form of the amyloid-β peptide in sporadic Alzheimer's disease. 2021 1
6 31922154 Complete identification of all 20 relevant epimeric peptides in β-amyloid: a new HPLC-MS based analytical strategy for Alzheimer's research. 2020 Feb 4 2
7 32881518 Relative Quantitation of Beta-Amyloid Peptide Isomers with Simultaneous Isomerization of Multiple Aspartic Acid Residues by Matrix Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. 2020 Jan 2 1
8 33052996 On the propagation of the OH radical produced by Cu-amyloid beta peptide model complexes. Insight from molecular modelling. 2020 Nov 1 1
9 31482121 Spontaneous Isomerization of Long-Lived Proteins Provides a Molecular Mechanism for the Lysosomal Failure Observed in Alzheimer's Disease. 2019 Aug 28 2
10 26175157 Mesotrypsin Has Evolved Four Unique Residues to Cleave Trypsin Inhibitors as Substrates. 2015 Aug 28 1
11 24617810 Turn plasticity distinguishes different modes of amyloid-β aggregation. 2014 Apr 2 1
12 24803226 Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer's disease. 2014 1
13 25178721 Sulforaphane interaction with amyloid beta 1-40 peptide studied by electrospray ionization mass spectrometry. 2014 Oct 30 1
14 23291379 Ethanol reduces amyloid aggregation in vitro and prevents toxicity in cell lines. 2013 Jan 1
15 23344882 A quantitative analysis of spontaneous isoaspartate formation from N-terminal asparaginyl and aspartyl residues. 2013 Apr 1
16 23484851 Effect of sequence on the ionization behavior of a series of amphiphilic polypeptides. 2013 Apr 9 3
17 23660814 Molecular dynamics simulation and molecular docking studies of Angiotensin converting enzyme with inhibitor lisinopril and amyloid Beta Peptide. 2013 Jun 2
18 23888782 [Identification of the minimal zinc-binding center in natural isoforms of amyloid-beta domain 1-16 using ESI-MS]. 2013 May-Jun 1
19 23904252 In silico and in vitro studies to elucidate the role of Cu2+ and galanthamine as the limiting step in the amyloid beta (1-42) fibrillation process. 2013 Oct 2
20 24028142 Differential contribution of isoaspartate post-translational modifications to the fibrillization and toxic properties of amyloid β and the Asn23 Iowa mutation. 2013 Dec 15 1
21 24383085 Site-specific aspartic acid isomerization regulates self-assembly and neurotoxicity of amyloid-β. 2013 Nov 15 1
22 21500352 Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β'-site increases Aβ generation. 2011 May 2
23 21757705 Evidence for an extended hydrogen bond network in the binding site of the nicotinic receptor: role of the vicinal disulfide of the alpha1 subunit. 2011 Sep 16 1
24 22191059 On the involvement of copper binding to the N-terminus of the amyloid Beta Peptide of Alzheimer's disease: a computational study on model systems. 2011 1
25 20557062 Exploring the surface charge on peptide-gold nanoparticle conjugates by force spectroscopy. 2010 Jul 20 1
26 19402527 [Effect of isomerization of aspartate-7 on the binding of copper (II) ion by the beta-amyloid peptide]. 2009 Mar-Apr 1
27 18085519 The N-domain of angiotensin-converting enzyme specifically hydrolyzes the Arg-5-His-6 bond of Alzheimer's Abeta-(1-16) peptide and its isoAsp-7 analogue with different efficiency as evidenced by quantitative matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. 2008 2
28 18599641 The structure of the amyloid-beta peptide high-affinity copper II binding site in Alzheimer disease. 2008 Oct 1
29 17352478 Role of aspartate-1 in Cu(II) binding to the amyloid-beta peptide of Alzheimer's disease. 2007 Apr 4 1
30 17940047 Familial Alzheimer's disease mutations alter the stability of the amyloid beta-protein monomer folding nucleus. 2007 Oct 16 1
31 16301322 Structural changes of region 1-16 of the Alzheimer disease amyloid beta-peptide upon zinc binding and in vitro aging. 2006 Jan 27 1
32 15633197 Switching of turn conformation in an aspartate anion peptide fragment by NH . . . O- hydrogen bonds. 2005 1
33 15706615 Hydrolysis of the amyloid beta-peptide (A beta) 1-40 between Asp23-Val24 produces non-aggregating fragments. An electrospray mass spectrometric study. 2005 Feb 1
34 16091285 Effect of D-amino acids at Asp23 and Ser26 residues on the conformational preference of Abeta20-29 peptides. 2005 Sep 30 1
35 16246054 Expression and activity of beta-site amyloid precursor protein cleaving enzyme in Alzheimer's disease. 2005 Nov 2
36 12391606 Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease. 2002 Nov 1 1
37 12391608 In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients. 2002 Nov 1 1
38 11580253 Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. 2001 Oct 5 1
39 11604391 Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. 2001 Dec 21 2
40 11898552 Amyloid metabolism and secretases in Alzheimer's disease. 2001 Sep 1
41 10652302 The transmembrane aspartates in presenilin 1 and 2 are obligatory for gamma-secretase activity and amyloid beta-protein generation. 2000 Feb 4 2
42 10783238 Presenilin-1 differentially facilitates endoproteolysis of the beta-amyloid precursor protein and Notch. 2000 Apr 2
43 10922078 Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid beta-protein generation. 2000 Aug 1 3
44 11056541 Glycine 384 is required for presenilin-1 function and is conserved in bacterial polytopic aspartyl proteases. 2000 Nov 2
45 10095028 Immunohistochemical localization of amyloid beta-protein with amino-terminal aspartate in the cerebral cortex of patients with Alzheimer's disease. 1999 Mar 27 1
46 10521267 Zebrafish (Danio rerio) presenilin promotes aberrant amyloid beta-peptide production and requires a critical aspartate residue for its function in amyloidogenesis. 1999 Oct 12 1
47 9600199 N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits. 1998 Jan 1
48 8632167 Evaluation of cathepsins D and G and EC 3.4.24.15 as candidate beta-secretase proteases using peptide and amyloid precursor protein substrates. 1996 Jun 1
49 8738655 The effects of aspartic acid-bond isomerization on in vitro properties of the amyloid beta-peptide as modeled with N-terminal decapeptide fragments. 1996 Apr 2
50 8755488 Inhibition of amyloid beta-protein production in neural cells by the serine protease inhibitor AEBSF. 1996 Jul 1